| 12:00-17:00 | Laparoscopic suturing and intracorporeal knot-tying workshop | Managers: Gökalp OKUT, Mehmet TORUN, Murat GÜNER |
| 12:00 – 12:15 | Introduction & key principles | |
| 12:00 – 12:05 | Ergonomics and instrument handling | Gökalp OKUT |
| 12:05 – 12:10 | Needle positioning | Mehmet TORUN |
| 12:10 – 12:15 | Common technical errors | Murat GÜNER |
| 12:15 – 12:30 | Faculty live demonstration | |
| 12:15 – 12:18 | Needle loading | Gökalp OKUT |
| 12:18 – 12:21 | Needle driving | Mehmet TORUN |
| 12:21 – 12:25 | Intracorporeal knot tying | Murat GÜNER |
| 12:25 – 12:30 | Running suture | Gökalp OKUT |
| 12:30 – 13:15 | Module 1: Needle handling and precision suturing | |
| 12:30 – 12:45 | Needle loading | Mehmet TORUN |
| 12:45 – 13:00 | Needle transfer | Murat GÜNER |
| 13:00 – 13:15 | Target penetration exercises | Gökalp OKUT |
| 13:15 – 14:00 | Module 2: Intracorporeal knot-tying | |
| 13:15 – 13:30 | C-loop technique | Mehmet TORUN |
| 13:30 – 13:45 | Reverse C-loop technique | Murat GÜNER |
| 13:45 – 14:00 | Secure knot formation | Gökalp OKUT |
| 14:00 – 14:15 | Break | |
| 14:15 – 15:00 | Module 3: Interrupted and continuous suturing | |
| 14:15 – 14:30 | Interrupted sutures | Mehmet TORUN |
| 14:30 – 14:45 | Running sutures | Murat GÜNER |
| 14:45 – 15:00 | Defect closure exercises | Gökalp OKUT |
| 15:00 – 16:15 | Module 4: Simulated gastrointestinal anastomosis | |
| 15:00 – 15:25 | Enterotomy closure | Mehmet TORUN |
| 15:25 – 15:50 | Gastrotomy closure | Murat GÜNER |
| 15:50 – 16:15 | Anastomotic corner sutures | Gökalp OKUT |
| 16:15 – 16:50 | Module 5: Advanced challenges & error correction | |
| 16:15 – 16:22 | Difficult angles | Mehmet TORUN |
| 16:22 – 16:30 | Restricted working space | Murat GÜNER |
| 16:30 – 16:40 | Suture management | Gökalp OKUT |
| 16:40 – 16:50 | Faculty tips and tricks | Mehmet TORUN |
| 16:50 – 17:00 | Wrap-up & closing remarks | |
| 16:50 – 16:55 | Faculty feedback | Murat GÜNER |
| 16:55 – 17:00 | Course evaluation | Mehmet TORUN, Gökalp OKUT |
| 13:00-17:05 | Robotic surgery for gastric cancer : Current evidence, standardization and advanced techniques | Manager: Erman AYTAÇ |
| 13:00-13:05 | Welcome & course introduction | Chairs: Enver İLHAN, Erman AYTAÇ |
| 13:05-14:05 | Session I | Current evidence, patient selection and operative preparation | Chairs: Ali KOCATAŞ, Hüseyin ÇİYİLTEPE, Mehmet TORUN |
| 13:05-13:20 | Current evidence in robotic gastric cancer surgery | Mihai EFTIME |
| 13:20-13:35 | Patient selection throughout the learning curve and establishing a robotic gastric cancer program | Octavian POPESCU |
| 13:35-13:50 | Operating room organization, equipment and patient setup | Mehmet Celal KIZILKAYA |
| 13:50-14:05 | Surgical anatomy and anatomical landmarks for robotic gastric cancer surgery | Yılmaz ÖZDEMİR |
| 14:05-14:20 | Break | |
| 14:20-17:00 | Session II | Standardized robotic resections, advanced techniques and interactive case discussions | Chairs: Vasile BINTINTAN, Fatih ALTINTOPRAK, Orhan ARAS |
| 14:20-14:30 | Step-by-step standardized robotic gastric resection | Erman AYTAÇ |
| 14:30-14:45 | D2 lymphadenectomy: technical pearls for safe and reproducible dissection | Fatih ALTINTOPRAK |
| 14:45-15:00 | Esophagojejunostomy and gastrojejunostomy: technical options and decision making | Süleyman DEMİRYAS |
| 15:00-15:15 | Double-tract, roux-en-y, braun and omega reconstruction | Sercan YÜKSEL |
| 15:15-15:30 | Managing challenging situations in robotic gastric cancer surgery | Erman AYTAÇ |
| 15:30-17:00 | Interactive course | Expert-led hands-on dry lab: robotic suturing and reconstruction techniques | Chairs: Turgut DÖNMEZ, Ahmet SÜREK, Mert TANAL |
| 17:00-17:05 | Wrap-up, take-home messages & closing remarks | Erman AYTAÇ |
| tab13 | tab13 | tab13 |
| 07:30-08:30 | Session 1 | Simultaneous round table panels 1 | |
| Round Table Panel 1: T4a Gastric cancer-Where should we draw the line? | Chair: Maria BENCIVENGA | |
| Panelists: Mehmet Onur GÜL, Yiğit DÜZKÖYLÜ, Deniz TİKİCİ, Serhan DERİCİ, Halil YILDIZ, M. Kaan DEMİRCİOĞLU | ||
| Round Table Panel 2: Response to neoadjuvant therapy-Surgery or surveillance? | Chair: Stefan MÖNIG | |
| Panelists: Orhan ÜREYEN, Emir Fatih KAYA, Ömer ÖZDUMAN, Girayhan ÇELİK, Ömer ÇAĞLIYAN | ||
| Round Table Panel 3: Elderly and frail patients-How aggressive should surgery be? | Chair:Paulo KASSAB | |
| Panelists: Mehmet Akif ÜSTÜNER, Tolga ÖLMEZ, Ahmet Orhan SUNAR, Hüseyin ESİN, Tuba GÖÇMEN | ||
| Round Table Panel 4: MDT Decisions vs intraoperative reality | Chair: Antonio C. WESTON | |
| Panelists: İskan ÇALLI, Güray DUMAN, Mert GEDİK | ||
| Round Table Panel 6: Unexpected T4b invasion-Salvage strategies | Chair: Paolo MORGAGNI | |
| Panelists: Serkan ADEMOĞLU, Melih Can GÜL, Abidin Gazi ALAGÖZ, Emrah DADALI, Emrehan İNCİ | ||
| Round Table Panel 7: Imaging–Pathology discordance-Who is right? | Chairs: Ulysses RIBEIRO JR, Hilal ŞAHİN, Dudu SOLAKOĞLU KAHRAMAN | |
| Panelists: Cem OFLUOĞLU, Sercan YÜKSEL, Mert ERCAN | ||
| Round Table Panel 8: Lymph node retrieval-Is the pathologist sufficient, or is surgical support needed? | Chair: Paulo Matos DA COSTA | |
| Panelists: M. Taha DEMİRPOLAT, Arif ATAY, Sami AÇAR, Merve YUMAK, Ata Mert ATEŞÇİ | ||
| Round Table Panel 9: CY1 disease-Induction therapy or upfront surgery? | Chair: Paul SCHNEIDER | |
| Panelists: Hüseyin ÇİYİLTEPE, Bahar CANBAY, Metin BOZKAYA, Atakan KILINÇ | ||
| Round Table Panel 10: Borderline resectable gastric cancer-Who truly benefits? | Chair: Masanori TERASHIMA | |
| Panelists: Orhan ARAS, Azmi LALE, Erman YEKENKURUL, Emrah CENGİZ, Enes CEBECİ | ||
| Round Table Panel 22 (Addition): CY1 disease-Induction therapy or upfront surgery? | Chair: Filippo PIETRANTONIO (Online) | |
| Panelists: Özlem KUTLU, Seval AKAY, Damla GÜNENÇ EŞİM | ||
| 08:40-09:40 | Session 2 | Preoperative assessment-Gray zones | Chairs: Osman YÜKSEL, Erman AYTAÇ, Turgut DÖNMEZ |
| 08:40-08:55 | CT / PET / DWI-MRI: When is imaging insufficient? | Hilal ŞAHİN |
| 08:55-09:10 | Staging laparoscopy: Who really needs it? | Antonio C. WESTON |
| 09:10-09:25 | Peritoneal cytology: Prognostic marker or therapeutic decision-maker? | Masanori TERASHIMA |
| 09:25-09:40 | Discussion | |
| 09:40-10:40 | Session 3 | Early-Stage gastric cancer-Management and decision-making | Chairs: Koray ATİLA, Ali GÜNER, Elçin AYDIN |
| 09:40-09:55 | Diagnosis and staging: endoscopic findings, biopsy, and radiologic assessment | Gözde DERVİŞ HAKİM |
| 09:55-10:10 | Surgical treatment options: Minimally invasive surgery vs endoscopic resection-where is the limit? (ESD indications and management after non-curative resection) | Takeshi SANO |
| 10:10-10:25 | Risk of lymph node metastasis: Implications for diagnosis and treatment strategy | Paulo Matos DA COSTA |
| 10:25-10:40 | Discussion | |
| 10:40-11:00 | Coffee Break | |
| 11:00-12:00 | Session 4 | Gastrectomy and D2 lymphadenectomy-Technical challenges | Chairs: Mehmet MİHMANLI, Fikret EZBERCİ, Akın Fırat KOCAAY |
| 11:00-11:15 | Surgery of “Difficult Stations”: 8p, 13, 16a1/b2, 14v, 10, 110–112 (Which approach is safer? When is each technique advantageous?) | Takeshi SANO |
| 11:15-11:30 | Subtotal, total, and proximal gastrectomy: Technical challenges in surgical decision - making (Patient selection and proximal/distal margin issues) | Yiğit DÜZKÖYLÜ |
| 11:30-11:45 | PIPAC: Experimental or evolving standard? | Orhan SUNAR |
| 11:45-12:00 | Discussion | |
|
12:00-12:30
|
Satellite session: CPS ≥ 5 in 1L Gastric cancer: Driving outcomes with OPDIVO® + Chemo | Timuçin ÇİL |
| 12:30-13:30 | Lunch | |
| 13:30-14:30 | Session 5 | Anastomosis and reconstruction-The most challenging decisions | Chairs: Salim DEMİRCİ, Recep ÇETİN, Erman AYTAÇ |
| 13:30-13:45 | Esophagojejunostomy (EJ): Circular vs linear stapling vs hand-sewn techniques | Carlos A. Garcia CARRASCO (Online) |
| 13:45-14:00 | Leak prevention strategies | Felix BERLTH |
| 14:00-14:15 | Double-tract reconstruction (DTR) vs Roux-en-Y vs interposition | Mehmet TORUN |
| 14:15-14:30 | Discussion | |
| 14:30-15:30 | Session 6 | Minimally invasive and robotic surgery-Is it truly superior? | Chairs: Cüneyt KAYAALP, Osman YÜKSEL, Ahmet SÜREK |
| 14:30-14:45 | Laparoscopic vs robotic surgery: Patient selection | Danielle MARRELLI |
| 14:45-15:00 | Robotic D2 Lymphadenectomy: Real advantage or illusion? | Paulo KASSAB |
| 15:00-15:15 | ICG-Guided surgery: Standard or overestimated? | Maria BENCIVENGA |
| 15:15-15:30 | Discussion | |
| 15:30-15:50 | Coffee break | |
| 15:50-16:50 | Session 7 | T4b Tumors and complex surgery-Where are the limits? | Chairs: Ahmet Serdar KARACA, Fatih Mehmet AVŞAR |
| 15:50-16:05 | Multivisceral Resection: How aggressive should we be? | Ulysses RIBEIRO JR |
| 16:05-16:20 | Initially cT4b Gastric Cancer: Should surgery be based on initial extent or post-treatment findings? | Çetin KOTAN |
| 16:20-16:35 | Major vascular and retroperitoneal invasion | Vasile BINTINTAN |
| 16:35-16:50 | Discussion | |
| 16:50-17:50 | Session 8 | Precision perioperative treatment strategies in resectable gastric cancer | Chairs: Şuayib YALÇIN, Mahmut İLHAN, Giovanni DE MANZONI |
| 16:50-17:05 | Perioperative systemic treatment intensification and total neoadjuvant strategies in resectable gastric cancer | Özgür TANRIVERDİ |
| 17:05-17:20 | MSI, CPS and ctDNA guided perioperative treatment selection in resectable gastric cancer | Ömer DİZDAR |
| 17:20-17:35 | HER2- and CLDN18.2-directed perioperative strategies: patient selection and ongoing clinical trials | Filippo PIETRANTONIO (Online) |
| 17:35-17:50 | Discussion | |
| 17:50-18:35 | Session 9 | Recent studies session | Chairs: Maria BENCIVENGA, Özlem ÖZDEMİR, Hüseyin ÇİYİLTEPE |
| 17:50-18:05 | IGCA International registry for metastatic gastric cancer | Erica SECCHETTIN |
| 18:05-18:30 | Turkish national consensus study (CONTRA-GAST Study) | Leyla ÖZER, Gökalp OKUT |
| 18:30-18:35 | National Gastric Cancer Academia | Mehmet TORUN |
| 19:00-19:30 | OPENING CEREMONY | |
| 07:40-08:40 | Session 10 | Oral presentation session | Chairs: Halil TAŞKAYNATAN, Cengiz AYDIN, Ali Kemal KAYAPINAR |
| 07:40-07:46 | 5226 - Predictors of overall and cancer-specific survival in primary gastric diffuse large b-cell lymphoma: A population-based cohort study | Şebnem ÇİMEN |
| 07:46-07:52 | 1794 - Pathological Tumor Size And Adverse Histopathological Features İn Gastric Pathological Tumor Size And Adverse Histopathological Features İn Gastric Cancer: Does Neoadjuvant Chemotherapy Matter? | Ali Eren DURMUŞ |
| 07:52-07:58 | 2420 - Time-related trends in the lauren classification of gastric adenocarcinoma: a single-center retrospective study | Ayşenur ÖZCAN |
| 07:58-08:04 | 8374 - Diagnostic Value Of Peritoneal Lavage Cytology İn Gastric Cancer: A 10-year single-center experience | İdil DOĞAN |
| 08:04-08:10 | 8763 - Histopathological features associated with tumor regression and residual lymph node disease in gastric cancers treated with neoadjuvant therapy | Rabia Nur ERTÜRK |
| 08:10-08:16 | 8703 - Frequency, localization, and demographic distribution of premalignant and malignant lesions in endoscopic biopsies of the upper gastrointestinal system: A retrospective analysis of 3,809 cases from a single center | Mücahit ÜNAL |
| 08:16-08:22 | 2564 - Clinical Impact Of Genetic Testing İn Gastric Tumors; The Selective Effect Of Variants And Family History | Saadet KOCA |
| 08:22-08:28 | 8995 - Should routine biopsy be performed for perforated gastric ulcers because of suspected malignancy? A systematic review | Cüneyt KAYAALP |
| 08:28-08.34 | 8712 - Histopathological Predictors of lymph node metastasis in gastric adenocarcinoma | Selinay SÖYLER |
| 08:34-08:40 | 9007 - Association of artificial ıntelligence-assisted tumor–stroma ratio assessment with tumor Biology in gastric ıntestinal-type adenocarcinomas | Simge BARAN |
| 08:40-09:40 | Session 11 | Debate session 1 | |
| 08:40-09:10 | Proximal margin in EGJ tumors: 3 cm vs 5 cm | Chairs: Mehmet YILDIRIM, Abdullah BÖYÜK, Serhan DERİCİ |
| 08:40-08:50 | 3 cm | Ulaş ADAY |
| 08:50-09:00 | 5 cm | Sercan YÜKSEL |
| 09:00-09:10 | Discussion | |
| 09:10-09:40 | PCI Threshold for CRS/HIPEC candidates: ≤6 vs 7–12 | Chairs: Yavuz ERYAVUZ, M. Reşit SÖNMEZ, Arif ATAY |
| 09:10-09:20 | PCI Score 7–12 | Abdullah ŞENLİKÇİ |
| 09:20-09:30 | PCI Score ≤ 6 | Mehmet TORUN |
| 09:30-09:40 | Discussion | |
| 09:40-10:00 | Coffee break | |
| 10:00-11:00 | Session 12 | Worst-case scenario panels 1 | |
| 10:00-10:30 | High-risk patient: 82 years old, cT4a, N+, sarcopenic, frail, unable to tolerate FLOT | Chairs: Aziz SÜMER, Mustafa Taner BOSTANCI, Adil KOYUNCU |
| 10:00-10:10 | Proceed with surgery-potential for cure | Serkan ADEMOĞLU |
| 10:10-10:20 | Do not operate-Harm outweighs benefit | Tolga ÖLMEZ |
| 10:20-10:30 | Discussion | |
| 10:30-11:00 | R0 Gastrectomy with D2 lymphadenectomy, followed by peritoneal recurrence at postoperative month 3 | Chairs: Musa AKOĞLU, Orhan ARAS |
| 10:30-10:40 | The surgery was appropriate-The biology was aggressive | Melih Can GÜL |
| 10:40-10:50 | The wrong patient was selected from the outset | Yılmaz ÖZDEMİR |
| 10:50-11:00 | Discussion | |
| 11:00 - 12:00 | Session 13 | Worst-case scenario panels 2 | |
| 11:00-11:30 | MSI-H Resectable gastric cancer: surgery first or immunotherapy first? | Chairs: Metin ERCAN, Mutlu DOĞAN, Turgut ANUK |
| 11:00-11:10 | Upfront surgery remains standard | Cem OFLUOĞLU |
| 11:10-11:20 | Neoadjuvant immunotherapy should be preferred in MSI-H disease | Deniz Can GÜVEN |
| 11:20-11:30 | Discussion | |
| 11:30-12:00 | Post-ESD case: SM2 invasion with LVI (+), patient fit | Chairs: Ali UZUNKÖY, Tahsin DALGIÇ, Fevzi CENGİZ |
| 11:30-11:40 | Completion gastrectomy is mandatory | Azmi LALE |
| 11:40-11:50 | Close Surveillance May Be Considered | Salim İlksen BAŞÇEKEN |
| 11:50-12:00 | Discussion | |
| 12:00-13:30 | Lunch | |
| 13:30-14:00 | Session 14 | Debate Session 2 | |
| Clinical stage II gastric cancer-Upfront D2 surgery for selected patients or perioperative therapy for all? | Chairs: Fatih ALTINTOPRAK, Orhan ÜREYEN, Ebubekir GÜNDEŞ | |
| 13:30-13:40 | Upfront D2 surgery for selected patients | İskan ÇALLI |
| 13:40-13:50 | Perioperative therapy for all | Arda Şakir YILMAZ |
| 13:50-14:00 | Discussion | |
| 14:00-15:00 | Session 15 | Nutritional management in challenging clinical scenarios in gastric cancer | Chairs: Savaş YAKAN, Kemal Erdinç KAMER, Bülent ÇALIK |
| 14:00-14:15 | Nutrition during neoadjuvant therapy in obstructive gastric cancer: what is the optimal approach? | Abidin Gazi ALAGÖZ |
| 14:15-14:30 | Nutrition after upper GI anastomotic leak: How should the strategy be determined? | Örgün GÜNEŞ |
| 14:30-14:45 | Post-gastrectomy nutrition: Early rehabilitation or controlled approach? | Ozan B. NAMDAROĞLU |
| 14:45-15:00 | Discussion | |
| 16:50-17:50 | Session 16 | Debate Session 3 | |
| 16:50-17:20 | Management of CY1 Disease: Upfront systemic therapy vs conversion surgery after cytology conversion | Chairs: Masanori TERASHIMA, Ali KOCATAŞ, Sami AÇAR |
| 16:50-17:00 | Upfront Systemic Therapy | Erman AKKUŞ |
| 17:00-17:10 | Conversion surgery if cytology turns negative | Paolo MORGAGNI |
| 17:10-17:20 | Discussion | |
| 17:20-17:50 | Re-Staging laparoscopy-Who should undergo it? Only patients with initial CY1/P1 disease vs all patients receiving neoadjuvant therapy (cT4 / Diffuse Type / Bulky N+) | Chairs: Yasuhiro KODERA, Nuri OKKABAZ, Enver REYHAN |
| 17:20-17:30 | Only patients with initial CY1/P1 disease | Mert TANAL |
| 17:30-17:40 | All patients receiving neoadjuvant therapy (cT4 / Diffuse Type / Bulky N+) | Murat GÜNER |
| 17:40-17:50 | Discussion | |
| 07:00-08:00 | Session 17 | Simultaneous round table panels 2 | |
| Round Table Panel 11: Anastomotic leakage-Prevention or damage control? | Chair: Felix BERLTH | |
| Panelists: Yiğit DÜZKÖYLÜ, İkbal OVALI ERDOĞDU, Mehmet Şah BENK, M. Kaan DEMİRCİOĞLU | ||
| Round Table Panel 12: Oligometastatic disease-True biology or stage migration artifact? | Chair: Giovanni DE MANZONI | |
| Panelists: Özlem ÖZDEMİR, Nidal İFLAZOĞLU, Gökalp OKUT, Mehmet Can AYDIN, Mehmet Fatih ERMAN | ||
| Round Table Panel 13: Conversion surgery-True success or selection bias? | Chair: Yasuhiro KODERA | |
| Panelists: Murat GÜNER, Mehmet Alperen UĞUR, Halil TÜRKAN, Demet ALAY | ||
| Round Table Panel 14: Obesity and gastric cancer? | Chair: Antonio C. WESTON | |
| Panelists:Aziz SÜMER, Orhan ÜREYEN, Melih Can GÜL, Ferhat ÇAY, Arda Şakir YILMAZ, Halil TAKCI, Şebnem ÇİMEN | ||
| Round Table Panel 15: Standardization in gastric cancer surgery-Is it achievable? | Chair: Daniele MARRELLI | |
| Panelists: Zeynep TAŞKIN, Mehmet Alperen AVCI, Furkan TAŞ, Yiğit Kaan ŞEN | ||
| Round Table Panel 16: High-risk patients-When should we avoid surgery? | Chair: Octavian POPESCU | |
| Panelists: Ayşe Gizem ÜNAL, Örgün GÜNEŞ, Necati Osman OKUMUŞ, Fadime KUTLUK | ||
| Round Table Panel 17: Complication-related mortality-Can it be predicted? | Chair: Takeshi SANO | |
| Panelists: Murat KARATAŞ, Ulaş ADAY, Deniz TİKİCİ, Ozan B. NAMDAROĞLU, Cemre DİNÇSOY | ||
| Round Table Panel 18: National Gastric Cancer Registry-Mandatory or voluntary? | Chair: Paolo MORGAGNI | |
| Panelists: Mehmet Onur GÜL, Yılmaz ÖZDEMİR, Mehmet TORUN, Gözde ERTUNÇ, Hasan Çağrı YILDIRIM, Riyad EZDEŞİR | ||
| Round Table Panel 19: CY1 disease-Induction therapy or upfront surgery? | Chair: Filippo PIETRANTONIO (Online) | |
| Panelists: Özlem Zeliha SERT, Özlem KUTLU, Merve YUMAK, Kübra CANASLAN | ||
| Round Table Panel 20: Early recurrence after curative surgery-What went wrong? | Chair: Enver İLHAN | |
| Panelists: Hilmi BOZKURT, Abdullah ŞENLİKÇİ, Kadir ÇORBACI, Mücahit ÜNAL, Mehmet Emin GÖNÜLLÜ, Gürkan GÜNERİ | ||
| Round Table Panel 21: Obesity and gastric cancer-2 | Chair: Vasile BINTINTAN | |
| Panelists: Çağrı BÜYÜKKASAP, Muzaffer Önder ÖNER, İbrahim SAYAR, Mert GEDİK, Mert Yiğit AKDOĞAN, Eyüp GEMİCİ, Vural ARGIN | ||
| Round Table Panel 5: R0 at all costs? Ethical and oncologic limits | Chair: Suzanne S. GISBERTZ | |
| Panelists: Salim İlksen BAŞÇEKEN, Mert TANAL, Ömer KUBAT, Anıl ORHAN, Emrehan İNCİ | ||
| 08:00-09:00 | Session 18 | Complications-“Hard sessions” | Chairs: Paulo KASSAB, Erdal Birol BOSTANCI |
| 08:00-08:15 | Surgery for recurrence: When is it justified? | Octavian POPESCU |
| 08:15-08:30 | Duodenal stump leak: Who is at risk? Management strategies | Mehmet Akif ÜSTÜNER |
| 08:30-08:45 | Esophagojejunostomy (EJ) Leak: Stent vs VAC vs surgical intervention | Paul SCHNEIDER |
| 08:45-09:00 | Discussion | |
| 09:00-09:30 | Session 19 | Debate Session 4 | |
| Siewert II EGJ Adenocarcinoma-Transthoracic esophagectomy or Transhiatal/Abdominal gastrectomy? | Chairs: Hasan KAPLAN, Evren DİLEKTAŞLI, Süleyman DEMİRYAS | |
| 09:00-09:10 | Transthoracic esophagectomy | Stefan MÖNIG |
| 09:10-09:20 | Transhiatal/Abdominal gastrectomy? | Vasile BINTINTAN |
| 09:20-09:30 | Discussion | |
| 09:40-10:40 | Session 20 | Risk stratification and recurrence prediction after curative treatment in gastric cancer | Chairs: Tuğba YAVUZŞEN, Suzanne S. GISBERTZ |
| 09:40-09:55 | Pathological response after neoadjuvant therapy: prognostic biomarker or guide for postoperative treatment adaptation? | Faysal DANE |
| 09:55-10:10 | Positive peritoneal cytology and occult peritoneal disease biology after curative treatment | Mehmet Ali ŞENDUR |
| 10:10-10:25 | Circulating tumor DNA (ctDNA) and minimal residual disease after curative treatment: toward biomarker-driven adjuvant strategies | Oktay Halit AKTEPE |
| 10:25-10:40 | Discussion | |
| 10:40-11:00 | Coffee Break | |
| 11:00-12:00 | Session 21 | Oligometastatic disease-Who should undergo surgery? | Chairs: Stefan MÖNIG, Paolo MORGAGNI, Enver İLHAN |
| 11:00-11:15 | Defining “True” oligometastatic disease: Diagnosis and management | Giovanni DE MANZONI |
| 11:15-11:30 | Conversion surgery: Who and when? | Yasuhiro KODERA |
| 11:30-11:45 | Lymph node–only metastasis (Para-aortic disease) | Daniele MARRELLI |
| 11:45-12:00 | Discussion | |
| 12:00-12:30 | GENERAL ASSEMBLY | |
| 12:30-13:30 | Lunch | |
| 13:30-14:30 | Session 22 | Peritoneal disease-The most controversial field | Chairs: Mustafa DUMAN, Lütfi DOĞAN, Yavuz ALBAYRAK, Burhan Hakan KANAT |
| 13:30-13:45 | Omentectomy debate: Total or partial – when is it necessary? (Current oncologic evidence and the pathophysiology of omental metastasis) | Suzanne S. GISBERTZ |
| 13:45-14:00 | HIPEC: Evidence vs hype | Özlem Zeliha SERT |
| 14:00-14:15 | Systemic + Intraperitoneal therapy: combination strategies | Mehmet TORUN |
| 14:15-14:30 | Discussion | |
| 14:30-15:30 | Session 23 | Recurrence-Where are the failures? | Chairs: Abdulkadir BEDİRLİ, Adam USLU, Alper SÖZÜTEK |
| 14:30-14:45 | Local vs systemic recurrence | M. Taha DEMİRPOLAT |
| 14:45-15:00 | Chylous leak: Current management approaches | Ali ALEMDAR |
| 15:00-15:15 | Modern systemic therapies in recurrent disease | Hasan Çağrı YILDIRIM |
| 15:15-15:30 | Discussion | |
| 15:30-15:50 | Coffee break | |
| 15:50-16:50 | Session 24 | Biomarker-driven systemic treatment strategies in metastatic gastric cancer | Chairs: Ömer Faruk ÖZKAN, Berk ÖZYILMAZ, Mehtat ÜNLÜ |
| 15:50-16:05 | First-Line immunotherapy strategies in metastatic gastric cancer: CPS-guided treatment selection and emerging predictive biomarkers | İlkay Tuğba ÜNEK |
| 16:05-16:20 | HER2-Positive metastatic gastric cancer: Treatment sequencing in the Trastuzumab-Deruxtecan era | Tarkan YETİŞYİĞİT (Online) |
| 16:20-16:35 | CLDN18.2, FGFR2b and next-generation antibody–drug conjugates in metastatic gastric cancer | Sezer SAĞLAM |
| 16:35-16:50 | Discussion | |
| 16:50-17:30 | Session 25 |Oral presentation awards and Closing Session | Chair: Enver İLHAN |
| 07:40-08:40 | Session 26 | Oral presentation session | Chairs: Erkan OYMACI, Seval AKAY |
| 07:40-07:46 | 9672 - Retrospective evaluation of the relationship between body composition analysis, tumor stage survival, and postoperative morbidity in patients with gastric adenocarcinoma receiving neoadjuvant chemotherapy and curative gastrectomy | Çağla DİNLER ŞENSÖZ |
| 07:46-07:52 | 1492 - Preoperative albumin level and ınflammatory-nutritional biomarkers as predictors of postoperative complications in curative gastrectomy for gastric cancer: a single-center cohort study | Enes CEBECİ |
| 07:52-07:58 | 1230 - Comparison of clinicopathological features with microsatellite ınstability ın patients with gastric cancer | Ezgi ALTINTAŞ |
| 07:58-08:04 | 4600 - Association of the pre-treatment sii-pni score with pathologic response after neoadjuvant flot in gastric cancer: A single-center retrospective study | Güzide KOFALI AYAKDAŞ |
| 08:04-08:10 | 1172 - Endoscopic management of anastomotic leak following oesophagogastric cancer resection: A systematic review | James William BUTTERWORTH |
| 08:10-08:16 | 2944 - The effect of neoadjuvant chemotherapy on postoperative outcomes and survival in gastric cancer patients | Kayahan EYÜBOĞLU |
| 08:16-08:22 | 8289 - Evaluating neoadjuvant treatment efficacy in locally advanced gastric cancer: Predictors of pathological tumor regression | Leyla Zeynep TİGREL |
| 08:22-08:28 | 1275 - The role of preoperative inflammatory and nutritional markers in predicting postoperative infectious complications in gastric cancer surgery | Neslihan ALICI |
| 08:28-08.34 | 4474 - Is young-onset gastric adenocarcinoma more aggressive? A clinicopathological and histological comparison | Abidin Gazi ALAGÖZ |
| 08:34-08:40 | 5628 - From peripheral blood to pathological risk: Predicting nodal metastasis and lymphovascular invasion in gastric cancer | Mahmut Kaan DEMİRCİOĞLU |
| 08:40-09:45 | Session 27 | The future-Where is surgery heading? | Chairs: Ertuğrul Gazi ALKURT, Mustafa Taner BOSTANCI, İsmail ZİHNİ |
| 08:40-08:55 | Artificial intelligence and decision support systems: will the role of the surgeon diminish? | Emir Gökhan KAHRAMAN |
| 08:55-09:10 | Video-based surgical quality assessment | Gözde ERTUNÇ |
| 09:10-09:25 | ERAS: Does it truly make a difference? | Ayşe Gizem ÜNAL |
| 09:25-09:35 | The use of AI in the academic studies | Mert ERCAN |
| 09:35-09:45 | Discussion | |
| 09:45-10.40 | Session 33 (Additional session) | Oral presentation session | Chairs: Gökalp OKUT, Çağrı BÜYÜKKASAP, Eyüp GEMİCİ |
| 09:45-09:52 | 7123 - The value of preoperative 18f-Fdg Pet/Ct and endoscopy in predicting surgical margin distance in gastric cancer surgery: Correlation with histopathological results | Enes CEBECİ |
| 09:52-09:58 | 3271 - Patients' experiences, perceptions and acceptability of prehabilitation before upper gastrointestinal cancer surgery: ‘my part in the fight’ | James William BUTTERWORTH |
| 09:58-10:04 | 4473 - “Can surgery be avoided in gastric minen? A case managed with endoscopic resection and close surveillance” | Mehmet Ömer ÖZDUMAN |
| 10:04-10:10 | 6837 - Descriptive statistics of home care patients with gastric cancer | Meryem AŞKIN |
| 10:10-10:16 | 1231 - Gastric cancer managed in a crs-hipec program: A single-center experience | Muhammed İkbal AKIN |
| 10:16-10:22 | 2250 - Nutritional reserve and the complication cascade after gastrectomy: a single-centre retrospective cohort study | Oğuzhan Hakan TOPGÜL |
| 10:22-10:28 | 4235 - The rapid rise of Pd-L1 Testing in gastric cancer: A 5-year trend analysis of 521 consecutive gastrectomies | Ömer ÇAĞLIYAN |
| 10:28-10:34 | 7792 - Macroscopy to metastasis: Predicting the relationship between borrmann classfication and metastasis | Yiğit Kaan ŞEN |
| 10:34-10:40 | 7643 - Management of choledocholithiasis with percutaneous transhepatic laser lithotripsy in surgically altered gastrointestinal anatomy: A video-assisted presentation of two cases | Buket HOROZ |
| 10:34-10:40 | 7058 - Robotic vs laparoscopic distal gastrectomy BI in gastric cancer patients with obesity: Short-term outcomes | Eihab MUNSHI |
| 10:40-11:00 | Coffee Break | |
| 11:00-12:00 | Session 28 | Selected oral presentations | Chairs: Kutay SAĞLAM, Özlem Zeliha SERT |
| 11:00-11:10 | 2943 - Pathological T stage and omental tumor involvement in gastric adenocarcinoma: A retrospective cohort study | Abidin Gazi ALAGÖZ |
| 11:10-11:20 | 7821 - Comparison of radiologist, surgeon, and multidisciplinary assessments in clinical staging of gastric cancer and factors associated with misstaging | Beyza İzem ERDEM |
| 11:20-11:30 | 5246 - Textbook outcome in patients with curative resection with D2 dissection for locally advanced gastric adenocarcinoma | Deniz Seniha ŞAHİN |
| 11:30-11:40 | 6974 - From operative narrative to structured surgical data in primary gastric malignancy: A multi-axial content analysis of 249 operative notes | Mert ERCAN |
| 11:40-11:50 | 7250 - Comparison of immunonutrition and standard nutritional support before gastrectomy after neoadjuvant FLOT | Muhammed Kadir YILDIRAK |
| 11:50-12:00 | 4237 - Is double-tract reconstruction inferior to roux-en-y reconstruction in proximal gastric cancer surgery? A retrospective analysis of functional and nutritional outcomes | Ömer KUBAT |
| 12:00-13:00 | Lunch | |
| 13:00-14:00 | Session 29 | Gastric precancerous lesions-Surgical boundaries and decision-making | Chairs: Ümit Haluk İLİKLERDEN, Bahar CANBAY |
| 13:00-13:10 | Helicobacter pylori eradication & cancer prevention: Too late or still effective? | Anıl ORHAN |
| 13:10-13:20 | Gastric polyps: When does endoscopic management become insufficient? | Kadir ÇORBACI |
| 13:20-13:30 | Gastric Dysplasia: Is ESD enough, or when should we proceed to surgery? | İkbal OVALI ERDOĞDU |
| 13:30-13:40 | Intestinal metaplasia: Surveillance or surgical intervention? | M. Kaan DEMİRCİOĞLU |
| 13:40-13:50 | Atrophic gastritis: Who needs surveillance? Who are we missing? | Muzaffer Önder ÖNER |
| 13:50-14:00 | Discussion | |
| 14:00-15:00 | Session 30: Early complications of gastric cancer surgery | Chairs: Mert TANAL, Girayhan ÇELİK |
| 14:00-14:10 | Intraoperative and early postoperative bleeding | Canberk TOY |
| 14:10-14:20 | Perioperative organ injuries in gastrectomy | Ömer ÖZDUMAN |
| 14:20-14:30 | Leak testing during gastrectomy: Which method works, if any? | Merve YUMAK |
| 14:30-14:40 | Internal herniation after laparoscopic gastrectomy: Prevention, early diagnosis, or surgical failure? | Mehmet Şah BENK |
| 14:40-14:50 | Intestinal obstruction due to peritonitis carcinomatosa | Halil TÜRKAN |
| 14:50-15:00 | Discussion | |
| 15:00-15:50 | Session 31 | Non-Adenocarcinoma gastric tumors-Surgical strategy and limits | Chairs: Hilmi BOZKURT, Mehmet Alperen AVCI |
| 15:00-15:10 | GIST: When does surgery become too aggressive? | Erman YEKENKURUL |
| 15:10-15:20 | Gastric lymphoma: Is there still a role for surgery in the modern era? | Deniz TİKİCİ |
| 15:20-15:30 | Gastric NETs: Local resection, formal gastrectomy, or observation? | Ömer KUBAT |
| 15:30-15:40 | Rare gastric tumors (e.g., leiomyosarcoma, schwannoma): Do we treat them like GIST? | Emrah DADALI |
| 15:40-15:50 | Discussion | |
| 15:50-16:00 | Session 32 Rational use of drugs | Chair: Mehmet YILDIRIM |
| 15:50-16:00 | Rational use of drugs | Berk ÖZYILMAZ |
| 16:00-17:00 | Session 34 (Additional session)| Oral presentation session | Chairs: Mehmet YILDIRIM, Orhan ÜREYEN, Murat GÜNER |
| 16:00-16:07 | 5303 - Preoperative halp score as an independent predictor of lymph node metastasis in gastric cancer | Olcay ATBAŞ |
| 16:14-16:21 | 1312 - Impact of stent timing on clinical outcomes of esophagojejunal anastomotic leakage after total gastrectomy for gastric cancer | Enes CEBECİ |
| 16:21-16:28 | 2391 - Surgical treatment of adrenal metastases from gastric cancer: A systematic review | Gökalp OKUT |
| 16:28-16:35 | 8009 - The importance of gag reflex and anxiety in determining the need for sedation in patients undergoing upper gastrointestinal system endoscopy: A prospective clinical study | Halil TÜRKAN |
| 16:35-16:42 | 5078 - Treatment outcomes for gastric gastrointestinal stromal tumors | Ilkin ISMAYILOV |
| 16:42-16:48 | 5308 - Risk of gastric cancer after liver transplantation: A meta-analysis | Kutay SAĞLAM |
| 16:48-16:54 | 2821 - Gastric splenosis and gastric accessory/ectopic spleen: A systematic review of 74 cases | Örgün GÜNEŞ |
| 16:54-17:00 | 7937 - Histologic spectrum of surgically resected gastric neuroendocrine neoplasms and aggressive pathologic features of minen: A single-center experience | Tarık YILDIZ |